Neuro-Oncology Reviews
Volume
25 Number 4
28 February 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 4, 28 February
*
Burns J, Guley N, Gokden M, Petersen E, Virmani T.
Glioblastoma,
IDH-Wildtype, CNS WHO Grade 4, Associated with Deep Brain
Stimulation in a Patient with Essential Tremor: Report of a Case
with Molecular Characterization, and Review of the Literature.
Mov
Disord Clin Pract. 2023 Feb 16;10(3):526-528∟.
doi: 10.1002/mdc3.13672∟.
PMID: 36949788∟.
Case report, Review˰ ˍ
Pant A, Lim
M.
CAR-T
Therapy in GBM: Current Challenges and Avenues for
Improvement.
Cancers
(Basel). 2023 Feb 16;15(4):1249∟.
doi: 10.3390/cancers15041249∟.
PMID: 36831591∟.
Review. ˍ
Hamad A,
Yusubalieva GM, Baklaushev VP, Chumakov PM, Lipatova AV.
Recent
Developments in Glioblastoma Therapy: Oncolytic Viruses and
Emerging Future Strategies.
Viruses.
2023 Feb 16;15(2):547∟.
doi: 10.3390/v15020547∟.
PMID: 36851761∟.
Review. ˍ
Mantica M, Drappatz J.
Immunotherapy
associated central nervous system complications in primary brain
tumors.
Front
Oncol. 2023 Feb 16;13:1124198∟.
doi: 10.3389/fonc.2023.1124198∟.
PMID: 36874119∟.
Review. ˍ
Matsuhashi A, Tanaka S, Takami H, Nomura M, Ikemura M,
Matsubayashi Y, Shinoda Y, Yamada K, Sakai Y, Karasawa Y,
Takayanagi S, Saito N.
Recurrent
glioblastoma metastatic to the lumbar vertebra: A case report and
literature review: Surgical oncology.
Front
Oncol. 2023 Feb 16;13:1101552∟.
doi: 10.3389/fonc.2023.1101552∟.
PMID: 36874120∟.
Case report, Review. ˍ
Stella M,
Baiardi G, Pasquariello S, Sacco F, Dellacasagrande I, Corsaro A,
Mattioli F, Barbieri F.
Antitumor
Potential of Antiepileptic Drugs in Human Glioblastoma:
Pharmacological Targets and Clinical Benefits.
Biomedicines.
2023 Feb 16;11(2):582∟.
doi: 10.3390/biomedicines11020582∟.
PMID: 36831117∟.
Review. ˍ
Chalif EJ,
Foster C, Sack K, Patrick H, Mozaffari K, Rosner M.
Impact
of Extent of Resection and Adjuvant Therapy in Diffuse Gliomas of
the Spine.
Spine
J. 2023 Feb 17:S1529-9430(23)00074-8∟.
doi: 10.1016/j.spinee.2023.02.010∟.
PMID: 36804437∟.
Observational
study, Review˰ ˍ
Frederico SC, Darling C, Bielanin JP, Dubinsky AC, Zhang X,
Hadjipanayis CG, Kohanbash G.
Neoadjuvant
immune checkpoint inhibition in the management of glioblastoma:
Exploring a new frontier.
Front
Immunol. 2023 Feb 17;14:1057567∟.
doi: 10.3389/fimmu.2023.1057567∟.
PMID: 36875096∟.
Review.
ˍ
Ibne Mokbul
M, Siddik AB.
Relationship
between glioblastoma multiforme (GBM) and Alzheimer's disease
(AD): is there any reporting bias?
Med
Oncol. 2023 Feb 21;40(3):101∟.
doi: 10.1007/s12032-023-01951-9∟.
PMID: 36809382∟.
Editorial˰ ˍ
Tamai S,
Ichinose T, Nakada M.
Liquid
biomarkers in glioma.
Brain
Tumor Pathol. 2023 Feb 17∟.
doi: 10.1007/s10014-023-00452-x∟.
PMID: 36800124∟.
Review˰ ˍ
Angolkar M,
Paramshetti S, Halagali P, Jain V, Patil AB, Somanna
P.
Nanotechnological
advancements in the brain tumor therapy: a novel approach.
Ther
Deliv. 2023 Feb 21∟.
doi: 10.4155/tde-2022-0035∟.
PMID: 36802944∟.
Review˰ ˍ
De Roeck L,
Gillebert RC, van Aert RCM, Vanmeenen A, Klein M, Taphoorn MJB,
Gehring K, Lambrecht M, Sleurs C.
Cognitive
outcomes after multimodal treatment in adult glioma patients: A
meta-analysis.
Neuro
Oncol. 2023 Feb 21:noad045∟.
doi: 10.1093/neuonc/noad045∟.
PMID: 36809489∟.
Meta-analysis. ˍ
Fudaba H,
Wakimoto H.
Oncolytic
virus therapy for malignant gliomas: entering the new era.
Expert
Opin Biol Ther. 2023 Feb 21∟.
doi: 10.1080/14712598.2023.2184256∟.
PMID: 36809883∟.
Review˰ ˍ
Rossi J, Cavallieri F, Bassi MC, Biagini G, Rizzi R, Russo M,
Bondavalli M, Iaccarino C, Pavesi G, Cozzi S, Giaccherini L,
Najafi M, Pisanello A, Valzania F.
Efficacy
and Tolerability of Perampanel in Brain Tumor-Related Epilepsy: A
Systematic Review.
Biomedicines.
2023 Feb 21;11(3):651∟.
doi: 10.3390/biomedicines11030651∟.
PMID: 36979629∟.
Review.
ˍ
Schaff LR,
Mellinghoff IK.
Glioblastoma
and Other Primary Brain Malignancies in Adults: A Review.
JAMA.
2023 Feb 21;329(7):574-587∟.
doi: 10.1001/jama.2023.0023∟.
PMID: 36809318∟.
Review˰ ˍ
Guzman G,
Pellot K, Reed MR, Rodriguez A.
CAR
T-cells to treat brain tumors.
Brain
Res Bull. 2023 Feb 23:S0361-9230(23)00048-5∟.
doi: 10.1016/j.brainresbull.2023.02.014∟.
PMID: 36841424∟.
Review. ˍ
Luksik AS, Yazigi E, Shah P, Jackson CM.
CAR
T Cell Therapy in Glioblastoma: Overcoming Challenges Related to
Antigen Expression.
Cancers
(Basel). 2023 Feb 23;15(5):1414∟.
doi: 10.3390/cancers15051414∟.
PMID: 36900205∟.
Review.
ˍ
Sharma P, Aaroe A, Liang J, Puduvalli VK.
Tumor
microenvironment in glioblastoma: Current and emerging
concepts.
Neurooncol
Adv. 2023 Feb 23;5(1):vdad009∟.
doi: 10.1093/noajnl/vdad009∟.
PMID: 36968288∟.
Review.
ˍ
Barden MM,
Omuro AM.
Top
advances of the year: Neuro-oncology.
Cancer.
2023 Feb 24∟.
doi: 10.1002/cncr.34711∟.
PMID: 36825454∟.
Review˰ ˍ
Baqai MWS,
Tariq R, Shah Z, Bajwa MH, Shamim MS.
Quality
of life in survivors of pediatric medulloblastoma: a systematic
review and meta-analysis.
Childs
Nerv Syst. 2023 Feb 24∟.
doi: 10.1007/s00381-023-05886-4∟.
PMID: 36826523∟.
Review, Meta-analysis˰ ˍ
Schupper AJ,
Hadjipanayis CG.
Novel
approaches to targeting gliomas at the leading/cutting edge.
J
Neurosurg. 2023 Feb 24:1-9∟.
doi: 10.3171/2023.1.JNS221798(?). PMID: 36840741∟.
Review˰ ˍ
Eibl RH, Schneemann M.
Liquid biopsy
and glioblastoma.
Explor
Target Antitumor Ther. 2023 Feb 25;4(1):28-41∟.
doi: 10.37349/etat.2023.00121∟.
PMID: 36937320∟.
Review. ˍ
Della Pepa GM, Menna G, Olivi A.
Technical
Pearls to Effectively Use 5-ALA in Fluorescence-Guided Tumor
Resection-5 Lessons from the Operating Room.
Brain
Sci. 2023 Feb 27;13(3):411∟.
doi: 10.3390/brainsci13030411∟.
PMID: 36979221∟.
Technical notes, Guidelines. ˍ
Weller M, Le Rhun E, Van den Bent M, Chang SM, Cloughesy TF,
Goldbrunner R, Hong YK, Jalali R, Jenkinson MD, Minniti G, Nagane
M, Razis E, Roth P, Rudà R, Tabatabai G, Wen PY, Short SC,
Preusser M.
Diagnosis and management of
complications from the treatment of primary central nervous system
tumors in adults.
Neuro Oncol. 2023 Feb 27:noad038∟.
doi: 10.1093/neuonc/noad038∟.
PMID: 36843451∟.
Review.
ˍ
Kut C, Kleinberg L.
Radiotherapy,
lymphopenia and improving the outcome for glioblastoma: a
narrative review.
Chin
Clin Oncol. 2023 Feb 28;12(1):4∟.
doi: 10.21037/cco-22-94∟.
PMID: 36922353∟.
Review. ˍ
Thomas DL.
2021 updates to the World
Health Organization classification of adult-type and
pediatric-type diffuse gliomas: a clinical practice review.
Chin
Clin Oncol. 2023 Feb 28;12(1):7∟.
doi: 10.21037/cco-22-120∟.
PMID: 36922356∟.
Review. ˍ
Zhou Z, Zhu B, Meng Q, Zhang T, Wu Y, Yu R, Gao S.
Research
progress in molecular pathology markers in medulloblastoma.
Explor
Target Antitumor Ther. 2023 Feb 28;4(1):139-156∟.
doi: 10.37349/etat.2023.00126∟.
PMID: 36937322∟.
Review. ˍ